Polpharma Biologics CEO Discusses Natalizumab Milestone

Q&A With Michael Soldan After CHMP Positive Opinion On Tysabri Biosimilar

 
• By David Wallace
Q&A written on wooden blocks, cubes
Polpharma Biologics CEO Michael Soldan discusses natalizumab • Source: Shutterstock

More from Biosimilars

More from Products